The Importance of Clinical Pharmacokinetic–Pharmacodynamic Studies in Unraveling the Determinants of Early and Late Tuberculosis Outcomes
International Journal of Pharmacokinetics · 2017
DOI: 10.4155/ipk-2017-0004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Pharmacokinetics, 2017. Verfasst von Andrew D McCallum und 1 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool School of Tropical Medicine, Pembroke Place, L3 5QA, Liverpool, UK. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Liverpool School of Tropical Medicine, Pembroke Place, L3 5QA, Liverpool, UK.
- Wellcome Trust Liverpool Glasgow Centre for Global Health Research, University of Liverpool, Liverpool L69 3GF, UK.
- Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
- School of Medicine, University of St Andrews, North Haugh, St Andrews, KY16 9TF, UK.
Förderung
- Wellcome Trust
Zitieren
APA
McCallum, A. D., & Sloan, D. J. (2017). The Importance of Clinical Pharmacokinetic–Pharmacodynamic Studies in Unraveling the Determinants of Early and Late Tuberculosis Outcomes. International Journal of Pharmacokinetics. https://doi.org/10.4155/ipk-2017-0004
Vancouver
McCallum AD, Sloan DJ. The Importance of Clinical Pharmacokinetic–Pharmacodynamic Studies in Unraveling the Determinants of Early and Late Tuberculosis Outcomes. International Journal of Pharmacokinetics. 2017. doi:10.4155/ipk-2017-0004
BibTeX
@article{McCallum2017,
author = {McCallum, Andrew D and Sloan, Derek J},
title = {The Importance of Clinical Pharmacokinetic–Pharmacodynamic Studies in Unraveling the Determinants of Early and Late Tuberculosis Outcomes},
journal = {International Journal of Pharmacokinetics},
year = {2017},
doi = {10.4155/ipk-2017-0004}
}
EUVIMED